Immunogenicity and Safety of an Investigational Hexavalent Vaccine Against Diphtheria, Tetanus, Pertussis (DTaP5), Polio (IPV), H. Influenzae Type b (Hib; PRP-OMPC), and Hepatitis B (HepB) Administered Concomitantly with RV5 and PCV-13 in US Infants